Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Chong Kun Dang Pharmaceutical, explained in plain language.
This study tests whether switching kidney transplant patients from their current maintenance drugs to either RaparoBell® or Myrept® is safe and effective. About 206 adults who had a kidney transplant 1-10 years ago are taking part. The goal is to see if the new drugs prevent reje…
Phase: PHASE4 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC